Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1951 1
1954 1
1955 1
1956 1
1965 1
1966 2
1967 3
1968 2
1969 1
1971 5
1972 6
1973 1
1974 5
1975 1
1976 8
1977 3
1978 3
1979 4
1980 3
1981 3
1982 5
1983 6
1984 3
1985 7
1986 9
1987 8
1988 7
1989 3
1991 10
1992 8
1993 4
1994 5
1995 5
1996 13
1997 11
1998 15
1999 17
2000 16
2001 21
2002 19
2003 27
2004 25
2005 14
2006 23
2007 31
2008 36
2009 40
2010 65
2011 66
2012 60
2013 74
2014 77
2015 79
2016 82
2017 106
2018 107
2019 109
2020 114
2021 117
2022 107
2023 103
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

1,587 results

Results by year

Filters applied: . Clear all
Page 1
S1‐Leitlinie Talgdrüsenkarzinom: S1‐Guideline Sebaceous Carcinoma.
Utikal J, Nagel P, Müller V, Becker JC, Dippel E, Frisman A, Gschnell M, Griewank K, Hadaschik E, Helbig D, Hillen U, Leiter U, Pföhler C, Krönig L, Ziemer M, Ugurel S. Utikal J, et al. Among authors: muller v. J Dtsch Dermatol Ges. 2024 May;22(5):730-749. doi: 10.1111/ddg.15405_g. J Dtsch Dermatol Ges. 2024. PMID: 38730519 German.
Determination of total extractable organofluorine (EOF) in food contact materials and target and non-target analysis of per- and polyfluoroalkyl substances using LC-MS/MS and LC-HRMS simultaneously coupled to ICP-MS.
Nxumalo T, Akhdhar A, Müller V, Al Zbedy A, Raab A, Jovanovic M, Leitner E, Kindness A, Feldmann J. Nxumalo T, et al. Among authors: muller v. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2024 May 10:1-11. doi: 10.1080/19440049.2024.2347491. Online ahead of print. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2024. PMID: 38728548
Disseminated necrotic plaques in a 50-year-old man.
Müller VL, Hillen U, Schaller J, Duschner N, Hyun J, Schrickel I, Kreuter A. Müller VL, et al. J Dtsch Dermatol Ges. 2024 May 8. doi: 10.1111/ddg.15413. Online ahead of print. J Dtsch Dermatol Ges. 2024. PMID: 38719550 No abstract available.
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Hack CC, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Ruebner M, Theuser AK, Hofmann NM, Böhm S, Almstedt K, Kellner S, Nabieva N, Gass P, Sütterlin MW, Lück HJ, Schmatloch S, Kalder M, Uleer C, Juhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Goossens C, Huebner H, Brucker SY, Häberle L, Fehm TN, Hein A, Fasching PA. Hack CC, et al. Among authors: muller v. Geburtshilfe Frauenheilkd. 2024 Apr 30;84(2):e10. doi: 10.1055/a-2314-3693. eCollection 2024 Feb. Geburtshilfe Frauenheilkd. 2024. PMID: 38690326 Free PMC article.
Extremophiles in a changing world.
Cowan DA, Albers SV, Antranikian G, Atomi H, Averhoff B, Basen M, Driessen AJM, Jebbar M, Kelman Z, Kerou M, Littlechild J, Müller V, Schönheit P, Siebers B, Vorgias K. Cowan DA, et al. Among authors: muller v. Extremophiles. 2024 Apr 29;28(2):26. doi: 10.1007/s00792-024-01341-7. Extremophiles. 2024. PMID: 38683238 Free PMC article. Review.
S1-Guideline Sebaceous Carcinoma.
Utikal J, Nagel P, Müller V, Becker JC, Dippel E, Frisman A, Gschnell M, Griewank K, Hadaschik E, Helbig D, Hillen U, Leiter U, Pföhler C, Krönig L, Ziemer M, Ugurel S. Utikal J, et al. Among authors: muller v. J Dtsch Dermatol Ges. 2024 May;22(5):730-747. doi: 10.1111/ddg.15405. Epub 2024 Apr 28. J Dtsch Dermatol Ges. 2024. PMID: 38679790
Patients' and dermatologists' preferences in AI-driven skin cancer diagnostics: prospective multicentric survey study.
Haggenmüller S, Maron RC, Hekler A, Krieghoff-Henning E, Utikal JS, Gaiser M, Müller V, Fabian S, Meier F, Hobelsberger S, Gellrich FF, Sergon M, Hauschild A, Weichenthal M, French LE, Heinzerling L, Schlager JG, Ghoreschi K, Schlaak M, Hilke FJ, Poch G, Korsing S, Berking C, Heppt MV, Erdmann M, Haferkamp S, Drexler K, Schadendorf D, Sondermann W, Goebeler M, Schilling B, Kather JN, Fröhling S, Kaminski K, Doppler A, Bucher T, Brinker TJ. Haggenmüller S, et al. Among authors: muller v. J Am Acad Dermatol. 2024 Apr 24:S0190-9622(24)00649-2. doi: 10.1016/j.jaad.2024.04.033. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38670313 Free article. No abstract available.
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients.
Massa C, Karn T, Weber K, Schneeweiss A, Hanusch C, Uwe Blohmer J, Zahm DM, Jackisch C, Mackelenbergh MV, Thomalla J, Marmé F, Huober J, Müller V, Schem C, Müller A, Stickeler E, Biehl K, Fasching PA, Untch M, Loibl S, Denkert C, Seliger B. Massa C, et al. Among authors: muller v. Clin Transl Med. 2024 Apr;14(4):e1617. doi: 10.1002/ctm2.1617. Clin Transl Med. 2024. PMID: 38664548 Free PMC article. No abstract available.
1,587 results